New consortium EUbOPEN will provide tools to unlock disease biolog
New consortium EUbOPEN will provide tools to unlock disease biolog
Search
From garbage to garden - Recycling organic waste to contribute to a healthier planet
From garbage to garden - Recycling organic waste to contribute to a healthier planet
Respiratory
Respiratory
Manufacturing & Supply Chain
Manufacturing & Supply Chain
Brazil
Brazil
Dubai
Dubai
Research Beyond Borders
Research Beyond Borders
Information Technology
IT
Human Health Partnering
Human Health Partnering
Parasiticides
Parasiticides
Championing Novel Science
Championing Novel Science
Technologies
Technologies
More Health Overview
Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.
Cardio-Renal-Metabolic diseases
Cardio-Renal-Metabolic diseases
A grandmother’s empathy offers a safe space for people with mental health conditions
Supporting the Friendship Bench to improve access to mental healthcare.
Mental Health disorders
Mental Health disorders
We’re All In
We’re All In
Animal Health Partnering
Animal Health Partnering
Vaccines
Vaccines
Boehringer Ingelheim to Acquire NBE-Therapeutics for EUR 1.18 Billion, Significantly Enhancing Its Cancer Pipeline Portfolio with Novel Antibody-Drug Conjugates
Boehringer Ingelheim to Acquire NBE-Therapeutics for EUR 1.18 Billion, Significantly Enhancing Its Cancer Pipeline Portfolio with Novel Antibody-Drug Conjugates
Animal Health Partnering Interests
Learn about our Partnering Interests and how we can work together to advance innovation in animal health
Metabolic Diseases
CardioMetabolic Disease Research
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*star for Targeted Cancer Therapies
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*star for Targeted Cancer Therapies
Citizen Petition
Citizen Petition
Boehringer Ingelheim and University of Dundee Highlight Successful PROTAC Drug Discovery Program and Extend Their Ongoing Anti-Cancer Alliance
Boehringer Ingelheim and University of Dundee Highlight Successful PROTAC Drug Discovery Program and Extend Their Ongoing Anti-Cancer Alliance